Dr. Wolinsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6410 Fannin St
Ste 1014
Houston, TX 77030Phone+1 832-325-7080Fax+1 713-512-2239
Summary
- Dr. Jerry Wolinsky is a neurologist in Houston, TX. He received his medical degree from University of Illinois College of Medicine at Chicago and has been in practice 48 years. He is experienced in multiple sclerosis, diffusion tensor imaging, encephalitis, magnetic resonance spectroscopy, and severity of illness index. He has more than 350 original publications and book chapters with over 60,000 citings. While retired from practice, he remains active as a consultant in clinical trials, and with the neuroimaging laboratory at UTHealth Houston.
Education & Training
- University of California (San Francisco)Residency, Neurology, 1970 - 1973
- University of California (San Francisco)/Mount ZionInternship, Transitional Year, 1969 - 1970
- University of Illinois College of MedicineClass of 1969
Certifications & Licensure
- TX State Medical License 1983 - 2024
- MD State Medical License 1978 - 1991
- CA State Medical License 1971 - 1978
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Join now to see all
Publications & Presentations
PubMed
- 3883 citationsDiagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".Chris H. Polman, Stephen C. Reingold, Gilles Edan, Massimo Filippi, Hans-Peter Hartung
Annals of Neurology. 2005-12-01 - 7536 citationsDiagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaChris H. Polman, Stephen C. Reingold, Brenda Banwell, Michel Clanet, Jeffrey A. Cohen
Annals of Neurology. 2011-02-01 - 194 citationsPlacebo-Controlled Trial of an Oral BTK Inhibitor in Multiple SclerosisXavier Montalban, Douglas L. Arnold, Martin S. Weber, Ivan Staikov, Karolina Piasecka-Stryczynska
The New England Journal of Medicine. 2019-05-10
Journal Articles
- Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple SclerosisJerry S Wolinsky, Lauren Krupp, Emmanuelle Waubant, Tanuja Chitnis, Brenda Banwell, Kevin Rostasy, The New England Journal of Medicine
Authored Content
- Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical TrialsJune 2020
Press Mentions
- Long-Term Ocrelizumab Shows Benefit in Progressive MSNovember 3rd, 2020
- Long-Term Ocrelizumab Benefits Seen in PPMSNovember 2nd, 2020
- #ECTRIMS2019 – Early Ocrevus Use Slows Disability in PPMS, Including Risk of Wheelchair RelianceSeptember 17th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: